IN2010CH03097A - - Google Patents

Download PDF

Info

Publication number
IN2010CH03097A
IN2010CH03097A IN3097CH2010A IN2010CH03097A IN 2010CH03097 A IN2010CH03097 A IN 2010CH03097A IN 3097CH2010 A IN3097CH2010 A IN 3097CH2010A IN 2010CH03097 A IN2010CH03097 A IN 2010CH03097A
Authority
IN
India
Prior art keywords
provides
present
tenofovir disoproxil
purification
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Dasari Muralidhara
Reddy Matta Ramakrishna
Krishna Bandi Vamsi
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Priority to IN3097CH2010 priority Critical patent/IN2010CH03097A/en
Publication of IN2010CH03097A publication Critical patent/IN2010CH03097A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3097CH2010 2010-10-20 2010-10-20 IN2010CH03097A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3097CH2010 IN2010CH03097A (ko) 2010-10-20 2010-10-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3097CH2010 IN2010CH03097A (ko) 2010-10-20 2010-10-20

Publications (1)

Publication Number Publication Date
IN2010CH03097A true IN2010CH03097A (ko) 2015-06-19

Family

ID=54397150

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3097CH2010 IN2010CH03097A (ko) 2010-10-20 2010-10-20

Country Status (1)

Country Link
IN (1) IN2010CH03097A (ko)

Similar Documents

Publication Publication Date Title
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MX2013008737A (es) Formas de dosificacion oral para tasocitinib que comprende liberacion modificada.
MX2012003343A (es) Proceso para preparar compuestos azabiciclicos.
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
MY170713A (en) Treatment protocol of diabetes type 2
MX336682B (es) Anticuerpos contra csf-1r humanos y usos de los mismos.
ZA201103820B (en) Process for the preparation of tenofovir
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
MX2014004196A (es) Citramida de rasagilina.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
WO2012070062A3 (en) Novel polymorph of nilotinib hydrochloride
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
MX362879B (es) Usos novedosos.
PH12013501859A1 (en) Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides
IN2013MU00646A (ko)
WO2012131707A3 (en) Crystalline form of bortezomib, preparation method and pharmaceutical composition there f
IN2012DN01292A (ko)
PH12013500210A1 (en) Highly crystalline valsartan
IN2012DN01929A (ko)
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
MY165088A (en) Pharmaceutical compositions comprising alisporivir
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.